From 9 February 2019, all prescription and reimbursable medicines on the market must bear safety features. At each link in the distribution chain, the safety features must be checked so that the authenticity of the medicine upon delivery can be guaranteed.
The system has come into full effect since 1 September 2019. From that time, alerts are being centrally evaluated and the FAMHP has started the monitoring activities through which violations and non-conformities will be followed up.
In addition, the information within the framework of the Falsified Medicines Directive is now included in the online medicines database:
- FMD (Falsified Medicines Directive) (Yes or no)
- FMD Code (Product code)
- ATD (anti-tampering device) (Yes or no)
Source: https://www.famhp.be/en/news/falsified_medicines_directive_end_of_transition_period_and_beginning_of_monitoring_activities https://www.famhp.be/en/news/information_on_the_falsified_medicines_directive_available_in_the_online_medicines_database